Profile image
Senior Research Fellow

Associate Professor Stuart Turville

Positions and Employment

1997                                   PhD graduate student (Virology)   

2003-2004                          Post-Doctoral Research Fellow                           KUL Leuven Belgium.

2004-2008                          Post-Doctoral Research Fellow                           Rockefeller University, New York USA       

2008-2011                          Research Fellow                                                    University of Sydney, Westmead Medical Research Institute

2011-2015                          Senior Research Fellow/Head,                             HIV Biology Group, Kirby  Institute. University of New South Wales

2015-Present                  Associate Professor                                                Kirby Institute, University of New South Wales

Phone
+61 (02) 9385 0462
E-mail
sturville@kirby.unsw.edu.au
Location
Presently Located The Kirby Institute, UNSW Australia , Office 527 Level 5 Wallace Wurth Building, , UNSW, Sydney NSW 2052
Jensen TO; Grandits GA; Jain MK; Murray TA; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV; Chen P; Dewar RL; Goodman AL; Hatlen TJ; Highbarger HC; Holodniy M; Lallemand P; Laverdure S; Leshnower BG; Looney D; Moschopoulos CD; Mugerwa H; Murray DD; Mylonakis E; Nagy-Agren S; Tauseef Rehman M; Rupert A; Stevens RA; Turville S; Weintrob A; Wick K; Lundgren J; Ko ER, 2024, 'Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19', Journal of Infectious Diseases, 229, pp. 671 - 679, http://dx.doi.org/10.1093/infdis/jiad446
2024
Bedding MJ; Franck C; Johansen-Leete J; Aggarwal A; Maxwell JWC; Patel K; Hawkins PME; Low JKK; Siddiquee R; Sani HM; Ford DJ; Turville S; Mackay JP; Passioura T; Christie M; Payne RJ, 2024, 'Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity', ACS Chemical Biology, 19, pp. 141 - 152, http://dx.doi.org/10.1021/acschembio.3c00568
2024
Faysal KMR; Walsh JC; Renner N; Márquez CL; Shah VB; Tuckwell AJ; Christie MP; Parker MW; Turville SG; Towers GJ; James LC; Jacques DA; Böcking T, 2024, 'Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure', eLife, 13, http://dx.doi.org/10.7554/eLife.83605
2024
Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8
2024
Zhang L; Dopfer-Jablonka A; Cossmann A; Stankov MV; Graichen L; Moldenhauer AS; Fichter C; Aggarwal A; Turville SG; Behrens GMN; Pöhlmann S; Hoffmann M, 2024, 'Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion', iScience, 27, http://dx.doi.org/10.1016/j.isci.2024.109904
2024
Jensen TO; Murray TA; Grandits GA; Jain MK; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV; Chen P; Dewar RL; Goodman AL; Hatlen TJ; Highbarger HC; Holodniy M; Lallemand P; Laverdure S; Leshnower BG; Looney D; Moschopoulos CD; Mugerwa H; Murray DD; Mylonakis E; Nagy-Agren S; Rehman MT; Rupert A; Stevens R; Turville S; Weintrob A; Wick K; Lundgren J; Ko ER; Sahner D; Tierney J; Vogel SE; Herpin BR; Smolskis MC; McKay LA; Cahill K; Crew P; Sardana R; Raim SS; Hensely L; Lorenzo J; Mock R; Zuckerman J; Atri N; Miller M; Vallee D; Chung L; Kang N; Barrett K; Adam SJ; Read S; Draghia-Akli R; Currier J; Hughes E; Harrigan RH; Amos L; Carlsen A; Carter A; Collins G; Davis B; Denning E; DuChene A; Eckroth K; Engen N; Frase A; Gandits G; Harrison M; Hurlbut N; Kaiser P; Koopmeiners J; Larson G; Meger S; Mistry SS; Murray T; Nelson R; Quan K; Quan SF; Reilly C; Siegel L; Thompson G; Vock D; Walski J; Gelijns AC; Moskowitz AJ; Bagiella E; Moquete E; O'Sullivan K; Marks ME; Accardi E; Kinzel E; Burris S; Bedoya G; Gupta L; Overbey JR; Santos M; Gillinov MA, 2024, 'Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study', The Lancet Microbe, 5, pp. e559 - e569, http://dx.doi.org/10.1016/S2666-5247(24)00015-6
2024
Singer J; Tunbridge MJ; Shi B; Perkins GB; Chai CS; Salehi T; Sim BZ; Kireta S; Johnston JK; Akerman A; Milogiannakis V; Aggarwal A; Turville S; Hissaria P; Ying T; Wu H; Grubor-Bauk B; Coates PT; Chadban SJ, 2024, 'Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial', Vaccines, 12, pp. 608 - 608, http://dx.doi.org/10.3390/vaccines12060608
2024
Harrison K; Carlos P; Ullrich S; Aggarwal A; Johansen-Leete J; Mini Sasi V; Barter I; Maxwell J; Bedding M; Larance M; Turville S; Jackson C; Norman A; Nitsche C; Payne RJ, 2024, 'Exploiting Hydrophobic Amino Acid Scanning to Develop Cyclic Peptide Inhibitors of the SARS-CoV-2 Main Protease with Antiviral Activity.', Chemistry, pp. e202401606, http://dx.doi.org/10.1002/chem.202401606
2024
Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J; Carey Hoppe A, 2023, 'Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses', American Journal of Hematology, 98, pp. 131 - 139, http://dx.doi.org/10.1002/ajh.26619
2023
Alcheikh A; Perkins GB; Pucar PA; Cecchin A; Chai CS; Tunbridge M; Akerman A; Aggarwal A; Milogiannakis V; Turville S; Allen S; Hissaria P; Banovic T; Coates PT; Ross DM, 2023, 'Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients', Blood Cancer Journal, 13, http://dx.doi.org/10.1038/s41408-023-00824-8
2023
Troelnikov A; Armour B; Putty T; Aggarwal A; Akerman A; Milogiannakis V; Chataway T; King J; Turville SG; Gordon TP; Wang JJ, 2023, 'Immunoglobulin repertoire restriction characterizes the serological responses of patients with predominantly antibody deficiency', Journal of Allergy and Clinical Immunology, 152, pp. 290 - 301.e7, http://dx.doi.org/10.1016/j.jaci.2023.02.033
2023
Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
2023
Loo L; Waller MA; Moreno CL; Cole AJ; Stella AO; Pop OT; Jochum AK; Ali OH; Denes CE; Hamoudi Z; Chung F; Aggarwal A; Low JKK; Patel K; Siddiquee R; Kang T; Mathivanan S; Mackay JP; Jochum W; Flatz L; Hesselson D; Turville S; Gregory Neely G, 2023, 'Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs', PLoS Biology, 21, http://dx.doi.org/10.1371/journal.pbio.3001967
2023
Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker GJ; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck HM; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, 2023, 'Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-36295-5
2023
Troelnikov A; Armour B; Putty T; Aggarwal A; Akerman A; Milogiannakis V; Chataway T; King J; Turville S; Gordon TP; Wang JJ, 2023, 'Imprinted repertoire restriction in immunodeficiency', Pathology, 55, pp. S28 - S28, http://dx.doi.org/10.1016/j.pathol.2022.12.093
2023
Poumbourios P; Langer C; Boo I; Zakir T; Center RJ; Akerman A; Milogiannakis V; Aggarwal A; Johnstone BA; Ha J; Coulibaly F; Turville SG; Drummer HE, 2023, 'Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1010981
2023
Rankin K; Hastak P; Wong A; Sasson SC; Beaton B; Yeola A; Warden A; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy', eJHaem, 4, pp. 728 - 732, http://dx.doi.org/10.1002/jha2.724
2023
Pillay A; Yeola A; Tea F; Denkova M; Houston S; Burrell R; Merheb V; Lee FXZ; Lopez JA; Moran L; Jadhav A; Sterling K; Lai CL; Vitagliano TL; Aggarwal A; Catchpoole D; Wood N; Phan TG; Nanan R; Hsu P; Turville SG; Britton PN; Brilot F, 2023, 'Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults', Journal of Clinical Immunology, 43, pp. 1706 - 1723, http://dx.doi.org/10.1007/s10875-023-01540-5
2023
Thijssen V; Hurdiss DL; Debski-Antoniak OJ; Spence MA; Franck C; Norman A; Aggarwal A; Mokiem NJ; van Dongen DAA; Vermeir SW; Liu M; Li W; Chatziandreou M; Donselaar T; Du W; Drulyte I; Bosch BJ; Snijder J; Turville SG; Payne RJ; Jackson CJ; van Kuppeveld FJM; Jongkees SAK, 2023, 'A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein', Proceedings of the National Academy of Sciences of the United States of America, 120, http://dx.doi.org/10.1073/pnas.2303292120
2023
Lee WS; Tan HX; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent HE; Aggarwal A; Turville SG; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson DA; Cromer D; Davenport MP; Kent SJ; Juno JA; Khoury DS; Wheatley AK, 2023, 'Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.adg5301
2023
Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C, 2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677
2023
Angelovich TA; Cochrane CR; Zhou J; Tumpach C; Byrnes SJ; Jamal Eddine J; Waring E; Busman-Sahay K; Deleage C; Jenkins TA; Hearps AC; Turville S; Gorry PR; Lewin SR; Brew BJ; Estes JD; Roche M; Churchill MJ, 2023, 'Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV', Annals of Neurology, 94, pp. 798 - 802, http://dx.doi.org/10.1002/ana.26750
2023
Girkin JLN; Bryant NE; Loo SL; Hsu A; Kanwal A; Williams TC; Maltby S; Turville SG; Wark PAB; Bartlett NW, 2023, 'Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-Modifying Therapies', American journal of respiratory cell and molecular biology, 69, pp. 614 - 622, http://dx.doi.org/10.1165/rcmb.2023-0202MA
2023
Body A; Ahern E; Lal L; Gillett K; Abdulla H; Opat S; O’Brien T; Downie P; Turville S; Munier CML; Smith C; MacIntyre CR; Segelov E, 2022, 'Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)', BMC Infectious Diseases, 22, http://dx.doi.org/10.1186/s12879-021-07019-1
2022
Aggarwal A; Stella A; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Lenthall H; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fitcher C; Hoppe AC; Munier ML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2022, 'SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', , http://dx.doi.org/10.21203/rs.3.rs-1207364/v1
2022
Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7
2022
Rankin K; Beaton B; Sasson S; Raedemaecker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Patel M; Klemm V; Munier CML; Carey Hoppe A; Tea F; Pillay A; Ospina A; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2022, 'PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA', HemaSphere, 6, pp. 1958 - 1959, http://dx.doi.org/10.1097/01.hs9.0000851180.32970.18
2022
Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', eBioMedicine, 84, http://dx.doi.org/10.1016/j.ebiom.2022.104270
2022
Counoupas C; Pino P; Stella AO; Ashley C; Lukeman H; Bhattacharyya ND; Tada T; Anchisi S; Metayer C; Martinis J; Aggarwal A; Dcosta BM; Britton WJ; Kint J; Wurm MJ; Landau NR; Steain M; Turville SG; Wurm FM; David SA; Triccas JA, 2022, 'High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens', Microbiology Spectrum, 10, http://dx.doi.org/10.1128/spectrum.01695-21
2022
Ashhurst AS; Tang AH; Fajtová P; Yoon MC; Aggarwal A; Bedding MJ; Stoye A; Beretta L; Pwee D; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng CT; Larance M; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ, 2022, 'Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L', Journal of Medicinal Chemistry, 65, pp. 2956 - 2970, http://dx.doi.org/10.1021/acs.jmedchem.1c01494
2022
Johansen-Leete J; Ullrich S; Fry SE; Frkic R; Bedding MJ; Aggarwal A; Ashhurst AS; Ekanayake KB; Mahawaththa MC; Sasi VM; Luedtke S; Ford DJ; O'Donoghue AJ; Passioura T; Larance M; Otting G; Turville S; Jackson CJ; Nitsche C; Payne RJ, 2022, 'Antiviral cyclic peptides targeting the main protease of SARS-CoV-2', Chemical Science, 13, pp. 3826 - 3836, http://dx.doi.org/10.1039/d1sc06750h
2022
Shen Y; Freeman JA; Holland J; Solterbeck A; Naidu K; Soosapilla A; Downe P; Tang C; Kerridge I; Wallman L; Van Bilsen N; Milogiannakis V; Akerman A; Martins Costa Gomes G; Sandgren K; Cunningham A; Turville S; Mulligan SP, 2022, 'COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity', British Journal of Haematology, 197, pp. 41 - 51, http://dx.doi.org/10.1111/bjh.18014
2022
Garcia-Valtanen P; Hope CM; Masavuli MG; Yeow AEL; Balachandran H; Mekonnen ZA; Al-Delfi Z; Abayasingam A; Agapiou D; Stella AO; Aggarwal A; Bouras G; Gummow J; Ferguson C; O'Connor S; McCartney EM; Lynn DJ; Maddern G; Gowans EJ; Reddi BAJ; Shaw D; Kok-Lim C; Beard MR; Weiskopf D; Sette A; Turville SG; Bull RA; Barry SC; Grubor-Bauk B, 2022, 'SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents', Cell Reports Medicine, 3, http://dx.doi.org/10.1016/j.xcrm.2022.100651
2022
Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2022, 'Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses', Cell Reports, 38, pp. 110345, http://dx.doi.org/10.1016/j.celrep.2022.110345
2022
Power H; Wu J; Turville S; Aggarwal A; Valtchev P; Schindeler A; Dehghani F, 2022, 'Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein', Bioorganic Chemistry, 119, http://dx.doi.org/10.1016/j.bioorg.2021.105574
2022
George PM; Reed A; Desai SR; Devaraj A; Faiez TS; Laverty S; Kanwal A; Esneau C; Liu MKC; Kamal F; Man WDC; Kaul S; Singh S; Lamb G; Faizi FK; Schuliga M; Read J; Burgoyne T; Pinto AL; Micallef J; Bauwens E; Candiracci J; Bougoussa M; Herzog M; Raman L; Ahmetaj-Shala B; Turville S; Aggarwal A; Farne HA; Pria AD; Aswani AD; Patella F; Borek WE; Mitchell JA; Bartlett NW; Dokal A; Xu XN; Kelleher P; Shah A; Singanayagam A, 2022, 'A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae', Science Translational Medicine, 14, http://dx.doi.org/10.1126/scitranslmed.abo5795
2022
Shen Y; Freeman JA; Holland J; Naidu K; Solterbeck A; Van Bilsen N; Downe P; Kerridge I; Wallman L; Akerman A; Aggarwal A; Milogiannakis V; Martins Costa Gomes G; Doyle CM; Sandgren KJ; Turville S; Cunningham AL; Mulligan SP, 2022, 'Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion', Blood, 140, pp. 2709 - 2721, http://dx.doi.org/10.1182/blood.2022017814
2022
Ashhurst AS; Johansen MD; Maxwell JWC; Stockdale S; Ashley CL; Aggarwal A; Siddiquee R; Miemczyk S; Nguyen DH; Mackay JP; Counoupas C; Byrne SN; Turville S; Steain M; Triccas JA; Hansbro PM; Payne RJ; Britton WJ, 2022, 'Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice', Nature Communications, 13, http://dx.doi.org/10.1038/s41467-022-34297-3
2022
Kim KW; Wang X; Adhikari A; Yeang M; Jenkins F; Naing Z; Walker GJ; Foster CSP; Stelzer-Braid S; Deveson I; Craig ME; Tedla N; Bull RA; Martinello M; Pinto AN; Chan R; Turville S; Rawlinson WD; van Hal S, 2022, 'Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia', Journal of Medical Virology, 94, pp. 4043 - 4046, http://dx.doi.org/10.1002/jmv.27832
2022
Segelov E; Body A; Lal L; Abdulla H; Turville S; Naing Z; Opat S; Leahy M; Balendra JR; Hamad N; Mccuaig R; Rao S; Lineburg K; Smith C; MacIntyre CR; Milch V; Busija L; Ahern ES, 2022, 'Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer', ANNALS OF ONCOLOGY, 33, pp. S1279 - S1279, http://dx.doi.org/10.1016/j.annonc.2022.07.1704
2022
Duette G; Hiener B; Morgan H; Mazur FG; Mathivanan V; Horsburgh BA; Fisher K; Tong O; Lee E; Ahn H; Shaik A; Fromentin R; Hoh R; Bacchus-Souffan C; Nasr N; Cunningham AL; Hunt PW; Chomont N; Turville SG; Deeks SG; Kelleher AD; Schlub TE; Palmer S, 2022, 'The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells', Journal of Clinical Investigation, 132, http://dx.doi.org/10.1172/JCI154422
2022
Spillings BL; Day CJ; Garcia-Minambres A; Aggarwal A; Condon ND; Haselhorst T; Purcell DFJ; Turville SG; Stow JL; Jennings MP; Mak J, 2022, 'Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry', Cell Reports, 38, http://dx.doi.org/10.1016/j.celrep.2022.110296
2022
Perkins GB; Tunbridge M; Salehi T; Chai CS; Kireta S; Johnston J; Penko D; Nitschke J; Yeow AEL; Al-Delfi Z; Drogemuller CJ; Garcia-Valtanen P; Masavuli MG; Hope CM; Singer J; Aggarwal A; Ospina Stella A; Turville SG; Hurtado PR; Barry SC; Hissaria P; Grubor-Bauk B; Chadban SJ; Coates PT, 2022, 'Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19', Kidney International, 101, pp. 1077 - 1080, http://dx.doi.org/10.1016/j.kint.2022.02.015
2022
Aggarwal A; Stella AO; Henry CC; Narayan K; Turville SG, 2022, 'Embedding of HIV Egress within Cortical F-Actin', Pathogens, 11, http://dx.doi.org/10.3390/pathogens11010056
2022
Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1032911
2022
Perkins G; Tunbridge M; Salehi T; Sheng Chai C; Hope CM; Garcia-Valtanen P; Singer JJ; Hurtado PR; Turville S; Hissaria P; Grubor-Bauk B; Barry SC; Chadban SJ; Coates AO T, 2022, '314.2: MTOR Inhibitors Promote Highly Functional T Cell Immunity in Kidney Transplant Recipients Vaccinated Against COVID-19', Transplantation, 106, pp. S223 - S223, http://dx.doi.org/10.1097/01.tp.0000886512.07666.7d
2022
Segelov E; Body A; Lal L; Abdulla H; Turville S; Naing Z; Opat S; Leahy M; Balendra JR; Hamad N; Mccuaig R; Rao S; Lineburg K; Smith C; MacIntyre CR; Milch V; Busija L; Ahern ES, 2022, '1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer', Annals of oncology : official journal of the European Society for Medical Oncology, 33, pp. S1279 - S1279
2022
Capraro A; Wong S; Adhikari A; Allan K; Patel H; Zhong L; Raftery M; Jaffe A; Yeang M; Aggarwal A; Wu L; Pandzic E; Whan R; Turville S; Vittorio O; Bull R; Kaakoush N; Rawlinson W; Tedla N; Vafaee F; Waters S, 2021, 'Ageing impairs the airway epithelium defence response to SARS-CoV-2', , http://dx.doi.org/10.1101/2021.04.05.437453
2021
Rouet R; Mazigi O; Walker GJ; Langley DB; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry JY; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull RA; Turville S; Stewart AG; Goodnow CC; Rawlinson WD; Christ D, 2021, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', mAbs, 13, http://dx.doi.org/10.1080/19420862.2021.1922134
2021
Li L; Honda-Okubo Y; Huang Y; Jang H; Carlock MA; Baldwin J; Piplani S; Bebin-Blackwell AG; Forgacs D; Sakamoto K; Stella A; Turville S; Chataway T; Colella A; Triccas J; Ross TM; Petrovsky N, 2021, 'Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection', Vaccine, 39, pp. 5940 - 5953, http://dx.doi.org/10.1016/j.vaccine.2021.07.087
2021
Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Fichter C; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffmann M; Pöhlman S; Mazigi O; Christ D; Rockett RJ; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003656
2021
Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Hutchings O; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, 2021, 'A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection', npj Vaccines, 6, http://dx.doi.org/10.1038/s41541-021-00406-4
2021
Burnett DL; Jackson KJL; Langley DB; Aggrawal A; Stella AO; Johansen MD; Balachandran H; Lenthall H; Rouet R; Walker G; Saunders BM; Singh M; Li H; Henry JY; Jackson J; Stewart AG; Witthauer F; Spence MA; Hansbro NG; Jackson C; Schofield P; Milthorpe C; Martinello M; Schulz SR; Roth E; Kelleher A; Emery S; Britton WJ; Rawlinson WD; Karl R; Schäfer S; Winkler TH; Brink R; Bull RA; Hansbro PM; Jäck HM; Turville S; Christ D; Goodnow CC, 2021, 'Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability', Immunity, 54, pp. 2908 - 2921.e6, http://dx.doi.org/10.1016/j.immuni.2021.10.019
2021
Estcourt LJ; Turgeon AF; McQuilten ZK; McVerry BJ; Al-Beidh F; Annane D; Arabi YM; Arnold DM; Beane A; Bégin P; Van Bentum-Puijk W; Berry LR; Bhimani Z; Birchall JE; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Callum JL; Chassé M; Cheng AC; Cove ME; Daly J; Derde L; Detry MA; De Jong M; Evans A; Fergusson DA; Fish M; Fitzgerald M; Foley C; Goossens H; Gordon AC; Gosbell IB; Green C; Haniffa R; Harvala H; Higgins AM; Hills TE; Hoad VC; Horvat C; Huang DT; Hudson CL; Ichihara N; Laing E; Lamikanra AA; Lamontagne F; Lawler PR; Linstrum K; Litton E; Lorenzi E; Maclennan S; Marshall J; McAuley DF; McDyer JF; McGlothlin A; McGuinness S; Miflin G; Montgomery S; Mouncey PR; Murthy S; Nichol A; Parke R; Parker JC; Priddee N; Purcell DFJ; Reyes LF; Richardson P; Robitaille N; Rowan KM; Rynne J; Saito H; Santos M; Saunders CT; Serpa Neto A; Seymour CW; Silversides JA; Tinmouth AA; Triulzi DJ; Turner AM; Van De Veerdonk F; Walsh TS; Wood EM; Berry S; Lewis RJ; Menon DK; McArthur C; Zarychanski R; Angus DC; Webb SA; Roberts DJ; Shankar-Hari M, 2021, 'Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients with COVID-19: A Randomized Clinical Trial', JAMA - Journal of the American Medical Association, 326, pp. 1690 - 1702, http://dx.doi.org/10.1001/jama.2021.18178
2021
Norman A; Franck C; Christie M; Hawkins PME; Patel K; Ashhurst AS; Aggarwal A; Low JKK; Siddiquee R; Ashley CL; Steain M; Triccas JA; Turville S; MacKay JP; Passioura T; Payne RJ, 2021, 'Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display', ACS Central Science, 7, pp. 1001 - 1008, http://dx.doi.org/10.1021/acscentsci.0c01708
2021
Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Warden A; Stella AO; Aggarwal A; Caterson ID; Phetsouphanh C; Turville S; Kelleher AD; Brilot F; Trotman J, 2021, 'Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149348
2021
Böcking T; Jacques DA; Lau D; Walsh JC; Dickson CF; Tuckwell A; Stear JH; Hunter DJB; Bhumkar A; Shah V; Turville SG; Sierecki E; Gambin Y, 2021, 'Rapid HIV-1 capsid interaction screening using fluorescence fluctuation spectroscopy', Analytical Chemistry, 93, pp. 3786 - 3793, http://dx.doi.org/10.1021/acs.analchem.0c04250
2021
Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA; Burnett D, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228
2021
Walker GJ; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD, 2021, 'Sars coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', Viruses, 13, http://dx.doi.org/10.3390/v13020247
2021
Fichter C; Aggarwal A; Wong AKH; McAllery S; Mathivanan V; Hao B; Macrae H; Churchill MJ; Gorry PR; Roche M; Gray LR; Turville S, 2021, 'Modular lentiviral vectors for highly efficient transgene expression in resting immune cells', Viruses, 13, http://dx.doi.org/10.3390/v13061170
2021
Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Warden A; Ospina Stella A; Aggarwal A; Caterson ID; Phetsouphanh C; Turville S; Kelleher AD; Brilot F; Trotman J, 2021, 'Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia', Blood, 138, pp. 816 - 816
2021
Van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R, 2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208
2020
Walker G; Clifford V; Bansal N; Stella AO; Turville S; Stelzer-Braid S; Klein L; Rawlinson W, 2020, 'SARS-CoV-2 in human milk is inactivated by Holder pasteurization but not cold storage', , http://dx.doi.org/10.1101/2020.06.18.20134395
2020
Walker G; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs S; Agapiou D; Bull R; Stelzer-Braid S; Daly J; Gosbell I; Hoad V; Irving D; Pink J; Turville S; Kelleher A; Rawlinson W, 2020, 'SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', , http://dx.doi.org/10.1101/2020.12.07.20245696
2020
Rouet R; Mazigi O; Walker G; Langley D; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry J; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull R; Turville S; Stewart A; Goodnow C; Rawlinson W; Christ D, 2020, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', , http://dx.doi.org/10.1101/2020.12.14.422791
2020
Walker GJ; Clifford V; Bansal N; Stella AO; Turville S; Stelzer-Braid S; Klein LD; Rawlinson W, 2020, 'SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage', Journal of Paediatrics and Child Health, 56, pp. 1872 - 1874, http://dx.doi.org/10.1111/jpc.15065
2020
Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffman M; Pöhlmann S; Dwyer DE; Rockett R; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2020, 'SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants', , http://dx.doi.org/10.1101/2020.12.19.20248567
2020
Lau D; Walsh JC; Mousapasandi A; Ariotti N; Shah VB; Turville S; Jacques DA; Böcking T, 2020, 'Self-Assembly of Fluorescent HIV Capsid Spheres for Detection of Capsid Binders', Langmuir, 36, pp. 3624 - 3632, http://dx.doi.org/10.1021/acs.langmuir.0c00103
2020
Stelzer-Braid S; Walker GJ; Aggarwal A; Isaacs SR; Yeang M; Naing Z; Ospina Stella A; Turville SG; Rawlinson WD, 2020, 'Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes', Pathology, 52, pp. 760 - 763, http://dx.doi.org/10.1016/j.pathol.2020.09.012
2020
Ahlenstiel CL; Turville SG, 2019, 'Delivery of gene therapy to resting immune cells for an HIV cure', Current Opinion in HIV and AIDS, 14, pp. 129 - 136, http://dx.doi.org/10.1097/COH.0000000000000531
2019
Rhodes JW; Tong O; Harman AN; Turville SG, 2019, 'Human dendritic cell subsets, ontogeny, and impact on HIV infection', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.01088
2019
Márquez CL; Lau D; Walsh J; Faysal KMR; Parker MW; Turville SG; Böcking T, 2019, 'Fluorescence Microscopy Assay to Measure HIV-1 Capsid Uncoating Kinetics in vitro', Bio-protocol, 9, http://dx.doi.org/10.21769/BioProtoc.3297
2019
Bertram KM; Tong O; Royle C; Turville SG; Nasr N; Cunningham AL; Harman AN, 2019, 'Manipulation of mononuclear phagocytes by HIV: Implications for early transmission events', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.02263
2019
Hu W; Cai Y; Zhu Y; Li F; Stella AO; Tebas P; Mounzer K; Kostman J; Turville S; Montaner L, 2019, 'Cleaving HIV-1 provirus from ART-suppressed patient-derived resting CD4 T Cells using Cpf1/crRNA-array ribonucleotide protein packaged by CD4-targeting lentivirus-like particle', Journal of Virus Eradication, 5, pp. 55 - 56, http://dx.doi.org/10.1016/s2055-6640(20)30221-1
2019
Lau D; Walsh J; Peng W; Shah V; Turville S; Jacques D; Böcking T, 2019, 'Fluorescence biosensor for real-time interaction dynamics of host proteins with HIV-1 capsid tubes', , http://dx.doi.org/10.1101/619841
2019
Lau D; Walsh JC; Peng W; Shah VB; Turville S; Jacques DA; Böcking T, 2019, 'Fluorescence Biosensor for Real-Time Interaction Dynamics of Host Proteins with HIV-1 Capsid Tubes', ACS Applied Materials and Interfaces, 11, pp. 34586 - 34594, http://dx.doi.org/10.1021/acsami.9b08521
2019
Aggarwal A; Ospina Stella A; Henry C; Narayan K; Turville S, 2019, 'HIV corruption of the Arp2/3-Cdc42-IQGAP1 axis to hijack cortical F-Actin to promote cell-cell viral spread', , http://dx.doi.org/10.1101/2019.12.13.873612
2019
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G, 2018, 'Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46', Journal of Gene Medicine, 20, http://dx.doi.org/10.1002/jgm.3006
2018
Stella AO; Turville S, 2018, 'All-round manipulation of the actin cytoskeleton by HIV', Viruses, 10, http://dx.doi.org/10.3390/v10020063
2018
Márquez CL; Lau D; Walsh J; Shah V; McGuinness C; Wong A; Aggarwal A; Parker MW; Jacques DA; Turville S; Böcking T, 2018, 'Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis', eLife, 7, http://dx.doi.org/10.7554/eLife.34772
2018
Turville S; Kelleher A, 2018, 'Obituary: Remembering Professor David Cooper', Retrovirology, 15, pp. 40, http://dx.doi.org/10.1186/s12977-018-0418-1
2018
Xu Y; Phetsouphanh C; Suzuki K; Aggrawal A; Graff-Dubois S; Roche M; Bailey M; Alcantara S; Cashin K; Sivasubramaniam R; Koelsch KK; Autran B; Harvey R; Gorry PR; Moris A; Cooper DA; Turville S; Kent SJ; Kelleher AD; Zaunders J; Aggarwal A, 2017, 'HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells', Frontiers in Immunology, 8, pp. 376, http://dx.doi.org/10.3389/fimmu.2017.00376
2017
Aggarwal A; Turville SG, 2017, '

Resolving the Sites of HIV Entry: Dynamin Networks Hold the Key

'
, JCS, 2, pp. 1 - 10, http://dx.doi.org/10.4172/2576-1471.1000173
2017
Aggarwal A; Hitchen TL; Ootes L; McAllery S; Wong A; Nguyen K; McCluskey A; Robinson PJ; Turville SG, 2017, 'HIV infection is influenced by dynamin at 3 independent points in the viral life cycle', Traffic, 18, pp. 392 - 410, http://dx.doi.org/10.1111/tra.12481
2017
McAllery SA; Ahlenstiel CL; Suzuki K; Symonds GP; Kelleher AD; Turville SG, 2016, 'The feasibility of incorporating Vpx into lentiviral gene therapy vectors', Molecular Therapy Methods and Clinical Development, 3, pp. 16066, http://dx.doi.org/10.1038/mtm.2016.66
2016
Ng WC; Londrigan SL; Nasr N; Cunningham AL; Turville S; Brooks AG; Reading PC, 2016, 'The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus', Journal of Virology, 90, pp. 206 - 221, http://dx.doi.org/10.1128/JVI.01447-15
2016
Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'P10.10 T-cells in the anal mucosa of men with high-grade squamous intraepithelial lesions', Sexually Transmitted Infections, 91, pp. A168.2 - A168, http://dx.doi.org/10.1136/sextrans-2015-052270.438
2015
Jayathunge PHM; McBride WJH; Maclaren D; Kaldor J; Vallely A; Turville S, 2015, 'Male circumcision and HIV transmission; What do we know?', Open AIDS Journal, 8, pp. 31 - 44, http://dx.doi.org/10.2174/1874613601408010031
2015
Ahlenstiel C; Mendez C; Lim STH; Marks K; Turville S; Cooper DA; Kelleher AD; Suzuki K, 2015, 'Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing', Molecular Therapy Nucleic Acids, 4, pp. e261, http://dx.doi.org/10.1038/mtna.2015.31
2015
Nasr N; Harman A; Turville S; Cunningham AL, 2014, 'HIV infection of dendritic cells', Methods in Molecular Biology, 1087, pp. 221 - 232, http://dx.doi.org/10.1007/978-1-62703-670-2-18
2014
Eyre NS; Fiches GN; Aloia AL; Helbig KJ; McCartney EM; McErlean CSP; Li K; Aggarwal A; Turville SG; Beard MR, 2014, 'Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection', Journal of Virology, 88, pp. 3636 - 3652, http://dx.doi.org/10.1128/JVI.02490-13
2014
Gray LR; Turville SG; HItchen TL; Cheng WJ; Ellett AM; Salimi H; Roche MJ; Wesselingh SL; Gorry PR; Churchill MJ, 2014, 'HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles', PLoS ONE, 9, pp. e90620, http://dx.doi.org/10.1371/journal.pone.0090620
2014
Aggarwal A; Turville SG, 2014, 'Imaging HIV entry and egress', Microbiology Australia, 35, pp. 107 - 109, http://dx.doi.org/10.1071/ma14035
2014
Turville S, 2014, 'Blocking of HIV entry through CD44-hyaluronic acid interactions', Immunology and Cell Biology, 92, pp. 735 - 736, http://dx.doi.org/10.1038/icb.2014.66
2014
Turville SG; Nasr N; Lai J; Botting RA; Mercier SK; Harman AN; Kim M; Centre RJ; Domagala T; Gorry PR; Olbourne N; Cunningham AL, 2014, 'Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin', J Immunol, 193, pp. 2554 - 2564, http://dx.doi.org/10.4049/jimmunol.1400630
2014
Nasr N; Harman A; Turville S; Cunningham AL, 2014, 'HIV infection of dendritic cells', Methods in Molecular Biology, 1087, pp. 221 - 232, http://dx.doi.org/10.1007/978-1-62703-670-2_18
2014
Gray LR; Turville SG; Hitchen TL; Cheng WJ; Ellett AM, 2014, 'Correction: HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles (PLoS ONE (2014) 9, 2, (e90620) DOI:10.1371/journal.pone.0090620)', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0093417
2014
Mercier SK; Donaghy H; Botting RA; Turville SG; Harman AN; Nasr N; Ji H; Kusebauch U; Mendoza L; Shteynberg D; Sandgren K; Simpson RJ; Moritz RL; Cunningham AL, 2013, 'The Microvesicle Component of HIV-1 Inocula Modulates Dendritic Cell Infection and Maturation and Enhances Adhesion to and Activation of T Lymphocytes', PLoS Pathogens, 9, pp. e1003700, http://dx.doi.org/10.1371/journal.ppat.1003700
2013
Aggarwal A; Mcallery S; Turville S, 2013, 'Revising the role of myeloid cells in HIV pathogenesis', Current HIV/AIDS Reports, 10, pp. 3 - 11, http://dx.doi.org/10.1007/s11904-012-0149-1
2013
, 2013, 'The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes', PLoS ONE, http://dx.doi.org/10.1371/journal.pone.0062196
2013
Mercier SK; Donaghy H; Botting RA; Turville SG; Harman AN; Nasr N; Ji H; Kusebauch U; Mendoza L; Shteynberg D; Sandgren K; Simpson RJ; Moritz RL; Cunningham AL, 2013, 'Correction: The Microvesicle Component of HIV-1 Inocula Modulates Dendritic Cell Infection and Maturation and Enhances Adhesion to and Activation of T Lymphocytes', PLoS Pathogens, 9, http://dx.doi.org/10.1371/annotation/059beb14-db84-4836-9fef-ec351946025a
2013
Aggarwal A; Iemma T; Shih I; Newsome TP; Mcallery S; Cunningham A; Turville S, 2012, 'Mobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cells', PLoS Pathogens, 8, pp. e1002762, http://dx.doi.org/10.1371/journal.ppat.1002762
2012
Nasr N; Maddocks S; Turville S; Harman AN; Woolger N; Helbig KJ; Wilkinson J; Bye CR; Wright TK; Rambukwelle D; Donaghy H; Beard MR; Cunningham AL, 2012, 'HIV-1 infection of human macrophages directly induces viperin which inhibits viral production.', Blood, 120, pp. 778 - 788, http://dx.doi.org/10.1182/blood-2012-01-407395
2012
Purcell DJ; Cunningham AL; Turville S; Tachedjian TG; Landay A, 2012, 'Biology of Mucosally Transmitted Sexual Infection-Translating the Basic Science into Novel HIV Intervention: A Workshop Summary', AIDS Research and Human Retroviruses, 28, pp. 1389 - 1396, http://dx.doi.org/10.1089/aid.2012.0276
2012
Gray L; Tachedjian G; Ellett A; Roche M; Brew B; Turville S; Wesselingh S; Gorry P; Churchill M, 2012, 'Reduced Effectiveness of the NRTIs d4T and AZT in Astrocytes: Implications for Neuro-cART', JOURNAL OF NEUROVIROLOGY, 18, pp. 42 - 43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Londrigan SL; Turville SG; Tate MD; Deng YM; Brooks AG; Reading PC, 2011, 'N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN', Journal of Virology, 85, pp. 2990 - 3000, http://dx.doi.org/10.1128/JVI.01705-10
2011
Harman AN; Lai J; Turville S; Samarajiwa S; Gray L; Marsden V; Mercier S; Jones K; Nasr N; Rustagi A; Cumming H; Donaghy H; Mak J; Gale M; Churchill M; Hertzog P; Cunningham AL, 2011, 'HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production', Blood, 118, pp. 298 - 308, http://dx.doi.org/10.1182/blood-2010-07-297721
2011
Keller CW; Fokken C; Turville SG; Lünemann A; Schmidt J; Münz C; Lünemann JD, 2011, 'TNF-α induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells', Journal of Biological Chemistry, 286, pp. 3970 - 3980, http://dx.doi.org/10.1074/jbc.M110.159392
2011
Harman AN; Lai J; Turville S, 2011, 'HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production (Blood (2011) 118, 2 (298-308))', Blood, 118, pp. 6992, http://dx.doi.org/10.1182/blood-2011-10-384719
2011
Cunningham AL; Abendroth A; Jones C; Nasr N; Turville S, 2010, 'Viruses and Langerhans cells', Immunology and Cell Biology, 88, pp. 416 - 423, http://dx.doi.org/10.1038/icb.2010.42
2010
Cunningham AL; Donaghy H; Harman AN; Kim M; Turville SG, 2010, 'Manipulation of dendritic cell function by viruses', Current Opinion in Microbiology, 13, pp. 524 - 529, http://dx.doi.org/10.1016/j.mib.2010.06.002
2010
Lai J; Bernhard OK; Turville SG; Harman AN; Wilkinson J; Cunningham AL, 2009, 'Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1', Journal of Biological Chemistry, 284, pp. 11027 - 11038, http://dx.doi.org/10.1074/jbc.M809698200
2009
Trapp S; Derby NR; Singer R; Shaw A; Williams VG; Turville SG; Bess JW; Lifson JD; Robbiani M, 2009, 'Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G', Journal of Virology, 83, pp. 884 - 895, http://dx.doi.org/10.1128/JVI.00023-08
2009
Harman AN; Kraus M; Bye CR; Byth K; Turville SG; Tang O; Mercier SK; Nasr N; Stern JL; Slobedman B; Driessen C; Cunningham AL, 2009, 'HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase', Blood, 114, pp. 85 - 94, http://dx.doi.org/10.1182/blood-2008-12-194845
2009
Schweizer A; Rusert P; Berlinger L; Ruprecht CR; Mann A; Corthésy S; Turville SG; Aravantinou M; Fischer M; Robbiani M; Amstutz P; Trkola A, 2008, 'CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics', PLoS Pathogens, 4, http://dx.doi.org/10.1371/journal.ppat.1000109
2008
Turville SG; Aravantinou M; Miller T; Kenney J; Teitelbaum A; Hu L; Chudolij A; Zydowsky TM; Piatak M; Bess JW; Lifson JD; Blanchard J; Gettie A; Robbiani M, 2008, 'Efficacy of carraguard®-based microbicides in vivo despite variable in vitro activity', PLoS ONE, 3, http://dx.doi.org/10.1371/journal.pone.0003162
2008
Frank I; Stössel H; Gettie A; Turville SG; Bess JW; Lifson JD; Sivin I; Romani N; Robbiani M, 2008, 'A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells', Journal of Virology, 82, pp. 5329 - 5339, http://dx.doi.org/10.1128/JVI.01987-07
2008
Turville SG; Aravantinou M; Stössel H; Romani N; Robbiani M, 2008, 'Resolution of de novo HIV production and trafficking in immature dendritic cells', Nature Methods, 5, pp. 75 - 85, http://dx.doi.org/10.1038/nmeth1137
2008
Keller CW; Lee M; Turville SG; Bähr M; Münz C; Lünemann JD; Schmidt J, 2008, 'Akkumulation von beta-Amyloid im Skelettmuskel: Zytokin-induzierte Modulation von Makroautophagie', Aktuelle Neurologie, 35, http://dx.doi.org/10.1055/s-0028-1086702
2008
Fernández-Romero JA; Thorn M; Turville SG; Titchen K; Sudol K; Li J; Miller T; Robbiani M; Maguire RA; Buckheit RW; Hartman TL; Phillips DM, 2007, 'Carrageenan/MIV-150 (PC-815), a combination microbicide', Sexually Transmitted Diseases, 34, pp. 9 - 14, http://dx.doi.org/10.1097/01.olq.0000223287.46097.4b
2007
Trapp S; Turville SG; Robbiani M, 2006, 'Slamming the door on unwanted guests: Why preemptive strikes at the mucosa may be the best strategy against HIV', Journal of Leukocyte Biology, 80, pp. 1076 - 1083, http://dx.doi.org/10.1189/jlb.0206121
2006
Turville SG; Peretti S; Pope M, 2006, 'Lymphocyte-dendritic cell interactions and mucosal acquisition of SIV/HIV infection.', Curr Opin HIV AIDS, 1, pp. 3 - 9, http://dx.doi.org/10.1097/01.COH.0000194109.14601.20
2006
Lynch GW; Turville S; Carter B; Sloane AJ; Chan A; Muljadi N; Li S; Low L; Armati P; Raison R; Zoellner H; Williamson P; Cunningham A; Church WB, 2006, 'Marked differences in the structures and protein associations of lymphocyte and monocyte CD4: Resolution of a novel CD4 isoform', Immunology and Cell Biology, 84, pp. 154 - 165, http://dx.doi.org/10.1111/j.1440-1711.2005.01403.x
2006
Turville SG; Vermeire K; Balzarini J; Schols D, 2005, 'Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer', Journal of Virology, 79, pp. 13519 - 13527, http://dx.doi.org/10.1128/JVI.79.21.13519-13527.2005
2005
Sloane AJ; Raso V; Dimitrov DS; Xiao X; Deo S; Muljadi N; Restuccia D; Turville S; Kearney C; Broder CC; Zoellner H; Cunningham AL; Bendall L; Lynch GW, 2005, 'Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-1α responses', Immunology and Cell Biology, 83, pp. 129 - 143, http://dx.doi.org/10.1111/j.1440-1711.2004.01304.x
2005
Turville SG; Santos JJ; Frank I; Cameron PU; Wilkinson J; Miranda-Saksena M; Dable J; Stõssel H; Romani N; Piatak M; Lifson JD; Pope M; Cunningham AL, 2004, 'Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells', Blood, 103, pp. 2170 - 2179, http://dx.doi.org/10.1182/blood-2003-09-3129
2004
Turville S; Wilkinson J; Cameron P; Dable J; Cunningham AL, 2003, 'The role of dendritic cell C-type lectin receptors in HIV pathogenesis', Journal of Leukocyte Biology, 74, pp. 710 - 718, http://dx.doi.org/10.1189/jlb.0503208
2003
Kedzierska K; Crowe SM; Turville S; Cunningham AL, 2003, 'The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages', Reviews in Medical Virology, 13, pp. 39 - 56, http://dx.doi.org/10.1002/rmv.369
2003
Lynch GW; Slaytor EK; Elliott FD; Saurajen A; Turville SG; Sloane AJ; Cameron PU; Cunningham AL; Halliday GM, 2003, 'CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers', Experimental Dermatology, 12, pp. 700 - 711, http://dx.doi.org/10.1034/j.1600-0625.2003.00078.x
2003
Turville SG; Cameron PU; Derek H; Cunningham AL, 2002, 'C-type lectin-HIV attachment on dendritic cells:Innate immune recognition and processing or mediators of HIV transmission?', Trends in Glycoscience and Glycotechnology, 14, pp. 255 - 271, http://dx.doi.org/10.4052/tigg.14.255
2002
Turville SG; Cameron PU; Handley A; Lin G; Pöhlmann S; Doms RW; Cunningham AL, 2002, 'Diversity of receptors binding HIV on dendritic cell subsets', Nature Immunology, 3, pp. 975 - 983, http://dx.doi.org/10.1038/ni841
2002
Turville SG; Arthos J; MacDonald K; Lynch G; Naif H; Clark G; Hart D; Cunningham AL, 2001, 'HIV gp120 receptors on human dendritic cells', Blood, 98, pp. 2482 - 2488, http://dx.doi.org/10.1182/blood.V98.8.2482
2001
Turville SG; Cameron PU; Arthos J; MacDonald K; Clark G; Hart D; Cunningham AL, 2000, 'Sweet symphony', New Scientist, 166, pp. 11
2000
Lee WS; Tan H-X; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent H; Aggarwal A; Turville S; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson D; Cromer D; Davenport M; Kent S; Juno J; Khoury D; Wheatley A, 2023, Durable reprogramming of neutralising antibody responses following breakthrough Omicron infection, , http://dx.doi.org/10.1101/2023.02.19.23286159
2023
Perkins G; Tunbridge M; Chai CS; Hope C; Yeow AEL; Salehi T; Singer J; Shi B; Masavuli M; Mekonnen ZA; Garcia-Valtanen P; Kireta S; Johnston J; Drogemuller C; Sim B; Spencer S; Sallustio B; Comerford I; Bouras G; Weiskopf D; Sette A; Aggarwal A; Milogiannakis V; Akerman A; Turville S; Hurtado P; Ying T; Hissaria P; Barry S; Chadban S; Grubor-Bauk B; Coates T, 2023, mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients, , http://dx.doi.org/10.1101/2023.03.27.23287773
2023
Moreno C; Castanheira F; Stella AO; Chung F; Aggarwal A; Cole A; Loo L; Dupuy A; Kong Y; Hagimola L; Fenwick J; Coleman P; Willson M; Bui-Marinos M; Hesselson D; Gamble J; Passam F; Turville S; Kubes P; Neely G, 2023, P-Selectin promotes SARS-CoV-2 interactions with platelets and the endothelium, , http://dx.doi.org/10.1101/2023.02.13.528235
2023
Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson D; Manandhar B; Klemm V; Tan H-X; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville S; Kent S; Byrne A; Brew B; Darley D; Dore G; Kelleher A; Matthews G, 2023, Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection, , http://dx.doi.org/10.1101/2023.08.27.23294704
2023
Aggarwal A; Fichter C; Milogiannakis V; Akerman A; Ison T; Ruiz Silva M; Esneau C; Bartlett N; Burrell L; Patel S; Churchill M; Angelovich T; Parry R; Sng J; Neely G; Moreno C; Loo L; Kelleher A; Brilot F; Khromykh A; Turville SG, 2023, TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2, , http://dx.doi.org/10.1101/2023.09.22.558930
2023
Foster CSP; Walker G; Jean T; Wong M; Brassil L; Isaacs S; Lyu Y; Turville S; Kelleher A; Rawlinson W, 2023, Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution, , http://dx.doi.org/10.1101/2023.11.02.565396
2023
Perkins G; Hope C; Chai CS; Tunbridge M; Sterling S; Webb K; Yap J; Yeow AEL; Masavuli M; Kireta S; Zuiani J; Akerman A; Aggarwal A; Milogiannakis V; Roberts M; Wilson W; Hurtado P; Turville S; Grubor-Bauk B; Barry S; Coates T; Ravindran J; Hissaria P, 2023, Immune profiling of COVID-19 vaccine responses in people with multiple sclerosis on B cell-depleting therapy, , http://dx.doi.org/10.1101/2023.12.04.23299409
2023
Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Coppola G; Yeang M; Jean T; Foster C; Hoppe AC; Ling Munier M; Darley D; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, , http://dx.doi.org/10.1101/2022.07.07.22277128
2022
Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks M; Law H; Danwilai T; Starr M; Munier ML; Christ D; Singh M; Croucher P; Brilot-Turville F; Turville S; Phan TG; Dore G; Darley D; Cunningham P; Matthews G; Kelleher A; Zaunders J, 2022, High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells, , http://dx.doi.org/10.1101/2022.07.22.22277947
2022
Aggarwal A; Stella A; Akerman A; Walker G; Milogiannakis V; McAllery S; Esneau C; Silva MR; Lu Y; Forster C; Hal SV; Mathivanan V; Fitcher C; Hoppe AC; Munier ML; Darley D; Matthews G; Starck D; Robosa R; Bartlett N; Rawlinson W; Kelleher A; Turville S, 2022, Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants, , http://dx.doi.org/10.21203/rs.3.rs-1210846/v1
2022
Rouet R; Henry J; Johansen M; Sobti M; Balachandran H; Langley D; Walker G; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett D; Brown S; Martinello M; Hudson B; Gilroy N; Post J; Kelleher A; Jäck H-M; Goodnow C; Turville S; Rawlinson W; Bull R; Stewart A; Hansbro P; Christ D, 2022, Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients, , http://dx.doi.org/10.1101/2022.10.19.512954
2022
Loo L; Waller M; Cole A; Stella A; Moreno C; Denes C; Hamoudi Z; Chung F; Aggarwal A; Low J; Patel K; Siddiquee R; Mackay J; Turville S; Hesselson D; Neely G, 2022, LRRC15 suppresses SARS-CoV-2 infection and controls collagen production, , http://dx.doi.org/10.21203/rs.3.rs-1172665/v1
2022
Poumbourios P; Langer C; Boo I; Zakir T; Center RJ; Akerman A; Milogiannakis V; Aggarwal A; Turville S; Drummer. HE, 2022, Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core, , http://dx.doi.org/10.1101/2022.11.08.515567
2022
Ashhurst A; Johansen M; Maxwell J; Ashley C; Aggarwal A; Siddiquee R; Miemczyk S; Nguyen D; Mackay J; Counoupas C; Byrne S; Turville S; Steain M; Triccas J; Hansbro P; Payne R; Britton W, 2022, Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice, , http://dx.doi.org/10.21203/rs.3.rs-1179181/v1
2022
Thijssen V; Hurdiss DL; Debski-Antoniak OJ; Spence MA; Franck C; Norman A; Aggarwal A; Mokiem NJ; van Dongen DAA; Vermeir SW; Liu M; Li W; Chatziandreou M; Donselaar T; Du W; Drulyte I; Bosch B-J; Snijder J; Turville S; Payne RJ; Jackson CJ; van Kuppeveld FJM; Jongkees SAK, 2022, A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein, , http://dx.doi.org/10.1101/2022.11.11.516114
2022
Faysal KMR; Walsh JC; Renner N; Marquez CL; Shah V; Tuckwell AJ; Christie MP; Parker MW; Turville SG; James L; Towers GJ; Jacques DA; Boecking T, 2022, Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure, , http://dx.doi.org/10.1101/2022.09.21.508807
2022
Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2022, Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level, , http://dx.doi.org/10.1101/2022.12.06.22283000
2022
Pillay A; Yeola A; Tea F; Denkova M; Houston S; Burrell R; Merheb V; Lee FXZ; Moran L; Jadhav A; Sterling K; Lai CL; Vitagliano TL; Aggarwal A; Catchpoole D; Wood N; Phan TG; Nanan R; Hsu P; Turville SG; Britton PN; Brilot F, 2022, Infection and vaccine induced Spike antibody responses against SARS-CoV-2 Variants of concern in immune naïve children and adults, , http://dx.doi.org/10.21203/rs.3.rs-2262275/v1
2022
Aggarwal A; Stella AO; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Henry J; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fichter C; Hoppe AC; Munier ML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2021, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, , http://dx.doi.org/10.1101/2021.12.14.21267772
2021
Counoupas C; Pino P; Stella A; Ashley C; Lukeman H; Bhattacharyya N; Tada T; Anchisi S; Metayer C; Martinis J; Aggarwal A; Dcosta B; Kint J; Wurm M; Landau N; Steain M; Turville S; Wurm F; David S; Triccas J, 2021, Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens, , http://dx.doi.org/10.1101/2021.08.18.456891
2021
Li L; Honda-Okubo Y; Huang Y; Jang H; Carlock MA; Baldwin J; Piplani S; Bebin-Blackwell AG; Forgacs D; Sakamoto K; Stella A; Turville S; Chataway T; Colella A; Triccas J; Ross TM; Petrovsky N, 2021, Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection, , http://dx.doi.org/10.1101/2021.07.03.451026
2021
Johansen-Leete J; Ullrich S; Fry S; Frkic R; Bedding M; Aggarwal A; Ashhurst A; Ekanayake K; Mahawaththa M; Sasi V; Passioura T; Larance M; Otting G; Turville S; Jackson C; Nitsche C; Payne R, 2021, Discovery of Antiviral Cyclic Peptides Targeting the Main Protease of SARS-CoV-2 via mRNA Display, , http://dx.doi.org/10.1101/2021.08.23.457419
2021
Loo L; Waller M; Moreno C; Cole A; Stella AO; Pop O-T; Jochum A-K; Ali OH; Denes C; Denes C; Hamoudi Z; Chung F; Aggarwal A; Low J; Patel K; Siddiquee R; Kang T; Mathivanan S; Mackay J; Flatz L; Hesselson D; Turville S; Neely G, 2021, Fibroblast-expressed LRRC15 suppresses SARS-CoV-2 infection and controls antiviral and antifibrotic transcriptional programs, , http://dx.doi.org/10.1101/2021.11.09.467981
2021
Garcia-Valtanen P; Hope C; Masavuli M; Lip Yeow AE; Balachandran H; Mekonnen Z; Al-Delfi Z; Abayasingam A; Agapiou D; Stella AO; Aggarwal A; Gummow J; Ferguson C; O’Connor S; McCartney E; Lynn D; Maddern G; Gowans E; Reddi BAJ; Shaw D; Kok-Lim C; Turville S; Beard M; Weiskopf D; Sette A; Bull R; Barry S; Grubor-Bauk B, 2021, COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection, , http://dx.doi.org/10.1101/2021.11.08.21266035
2021
Shen Y; Freeman JA; Holland J; Solterbeck A; Naidu K; Soosapilla A; Downe P; Tang C; Kerridge I; Wallman L; Van Bilsen N; Milogiannakis V; Akerman A; Martins Costa Gomes G; Sandgren K; Cunningham AL; Turville S; Mulligan SP, 2021, COVID-19 Vaccine Failure in Chronic Lymphocytic Leukemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity, , http://dx.doi.org/10.1101/2021.10.28.21265549
2021
Norman A; Franck C; Christie M; Hawkins P; Patel K; Ashhurst A; Aggarwal A; Low J; Siddiquee R; Ashley C; Steain M; Triccas J; Turville S; Mackay J; Passioura T; Payne R, 2020, Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein using mRNA Display, , http://dx.doi.org/10.1101/2020.12.22.424069
2020
Counoupas C; Johansen M; Stella A; Nguyen D; Ferguson A; Aggarwal A; Bhattacharyya N; Grey A; Patel K; Siddiquee R; Stewart E; Feng C; Hansbro N; Palendira U; Steain M; Saunders B; Low J; Mackay J; Kelleher A; Britton W; Turville S; Hansbro P; Triccas J, 2020, A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in mice, , http://dx.doi.org/10.1101/2020.12.10.419044
2020
Ashhurst AS; Tang AH; Fajtová P; Yoon M; Aggarwal A; Stoye A; Larance M; Beretta L; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng C-TK; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ, 2020, Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L., , http://dx.doi.org/10.1101/2020.12.23.424111
2020
Bull R; Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post J; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd A; Martinello M, 2020, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, , http://dx.doi.org/10.21203/rs.3.rs-92527/v1
2020
Lau D; Walsh J; Dickson C; Tuckwell A; Stear J; Hunter D; Bhumkar A; Shah V; Turville S; Sierecki E; Gambin Y; Böcking T; Jacques D, 2020, Rapid HIV-1 capsid interaction screening using fluorescence fluctuation spectroscopy, , http://dx.doi.org/10.1101/2020.11.13.382242
2020
Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Yeang M; Jean T; Foster C; Hoppe AC; Munier ML; Darley DR; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern, , http://dx.doi.org/10.2139/ssrn.4157473
Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson S; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer D; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses, , http://dx.doi.org/10.2139/ssrn.3920641
Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd AR; Martinello M; Bull RA; Group COSINS, Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2, , http://dx.doi.org/10.2139/ssrn.3732365
Wong AKH; Mathivanan V; Di Giallonardo F; Ahlenstiel C; Turville SG, A Molecular Basis for the Increased Transmission of Ebolavirus in Recent Outbreaks, , http://dx.doi.org/10.2139/ssrn.3507710
Akerman A; Milogiannakis V; Jean T; Esneu C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster C; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Sandgren KJ; Bull RA; Lloyd AR; Triccas J; Tangye SG; Bartlett NW; Darley DR; Matthews G; Starck D; Rawlinson W; Brilot F; Cunningham AL; Kelleher A; Aggarwal A; Turville S, Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level, , http://dx.doi.org/10.2139/ssrn.4295993
Czuba-Wojnilowicz E; Klemm V; Cortez-Jugo C; Turville S; Aggarwal A; Caruso F; Kelleher AD; Ahlenstiel CL, 2023, 'Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types', in Molecular Pharmaceutics, Vol. 20, pp. 2039 - 2052, http://dx.doi.org/10.1021/acs.molpharmaceut.2c01030
2023
Segelov E; Body A; Turville S; Smith C; Lineburg K; Rao S; McCuaig R; Opat S; Niang Z; Lal L; Luong V; Abdulla H; Lopez VA; Padhye B; Bolanos NF; Anazodo A; MacIntyre R; Downie P; O'Brien T; Ahern E, 2022, 'Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. CT567 - CT567, http://dx.doi.org/10.1158/1538-7445.am2022-ct567
2022
Body A; Ahern E; Abdulla H; Lal L; Turville S; Naing Z; Opat S; Leahy M; Hamad N; Lineburg K; Smith C; McCuaig R; Rao S; McIntyre R; Fuentes-Bolanos N; Padhye B; Busija L; Downie P; Milch V; Segelov E, 2022, 'Immune response to COVID-19 vaccination in adults and children with cancer: results from the prospective SerOzNET study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Segelov E; Body A; Luong VTT; Aedo Lopez V; Lal L; Abdulla H; Turville S; Naing Z; Opat S; McCuaig R; Rao S; Lineburg K; Smith C; MacIntyre C; Ahern ES, 2022, 'Humoral and cellular immune response to Sars-CoV-2 wild-type and variants of concern following 3-dose vaccination in a large cohort of adults with cancer: The SerOzNET study.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. LBA12065 - LBA12065, http://dx.doi.org/10.1200/jco.2022.40.17_suppl.lba12065
2022
Segelov E; Body A; Luong V; Lopez VA; Lal L; Abdulla H; Turville S; Niang Z; Opat S; McCuaig R; Lineburg K; Rao S; Smith C; MacIntyre R; Ahern E, 2022, 'Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. CT259 - CT259, http://dx.doi.org/10.1158/1538-7445.am2022-ct259
2022
Klemm V; Czuba-Wojnilowicz EI; Cortez-Jugo C; Turville SG; Caruso F; Kelleher AD; Ahlenstiel CL, 2020, 'Delivering Epigenetic Silencing Sirna to the Nucleus of Hiv-1 Infected Primary Activated Cd4+T-Cells via Nanoparticle System', in MOLECULAR THERAPY, CELL PRESS, ELECTR NETWORK, Vol. 28, pp. 468 - 469, presented at 23rd Annual Meeting of the American-Society-for-Gene-and-Cell-Therapy, ELECTR NETWORK, 12 May 2020 - 15 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530089302176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Xu Y; Bailey M; Phetsouphanh C; Harvey R; Turville S; Aggarwal A; Wong A; Suzuki K; Graff-Dubois S; Autran B; Moris A; Munier ML; Koelsch K; Kent S; Zaunders J; Kelleher A, 2016, 'Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 264 - 264, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000416106400440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Ognenovska K; Klemm V; Ledger S; Turville S; Symonds G; D. Kelleher A; L. Ahlenstiel C, 2019, 'Mechanisms for Controlling HIV-1 Infection: A Gene Therapy Approach', in In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders, IntechOpen, http://dx.doi.org/10.5772/intechopen.79669
2019
Ognenovska K; Klemm V; Ledger S; Turville S; Symonds G; Kelleher A; Ahlenstiel CL, 2018, 'Mechanisms for Controlling HIV-1 infection: a Gene Therapy Approach', in In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders, http://dx.doi.org/10.5772/intechopen.72962
2018
Vachot L; Turville SG; Trapp S; Peretti S; Morrow G; Frank I; Pope M, 2008, 'Sleeping with the Enemy: The Insidious Relationship between Dendritic Cells and Immunodeficiency Viruses', in Handbook of Dendritic Cells, pp. 773 - 811, http://dx.doi.org/10.1002/9783527619696.ch38
2008
Cunningham AL; Wilkinson J; Turville S; Pope M, 2007, 'Binding and uptake of HIV by dendritic cellsand transfer to T lymphocytes: Implicationsfor pathogenesis', in The Biology of Dendritic Cells and HIV Infection, pp. 381 - 404, http://dx.doi.org/10.1007/978-0-387-33785-2_10
2007
Cunningham A; Wilkinson J; Turville S; Bosnjak L; Dable J; Lai J; Nicolle M, 2005, 'Interaction of human epithelial dendritic cells with HIV and Herpes Simplex virus', in TISSUE ANTIGENS, BLACKWELL PUBLISHING, AUSTRALIA, Melbourne, pp. 387 - 388, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, AUSTRALIA, Melbourne, 29 November 2005 - 02 December 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2005

1. Title:

Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE): MRF2015313

Chief investigators:

G Matthews, N Dharan, A Kelleher, V Wiseman, S Turville, S Tong, B Barber, G Dore, J McMahon, C Dobler, B Rogers, S Maddocks, M Boyd, J Trevillyan, J Robinson

Role in Project:

CIE

Source and Scheme:

MRFF:

Commencement date:

January 2023

Duration:

5 years

Total Amount AUD$:

$1993166

 

 

2. Title:

Comparing Immunisation-boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies (CIRCUIT Study): MRF2015313

Chief investigators:

S Sasson, A Kelleher, K Petoumenos, M Davenport, J Trotman, F Brilot, S Turville,  N Hamad, R Bull, G Ahlenstiel

Role in Project:

CIG

Source and Scheme:

MRFF:

Commencement date:

June 2022

Duration:

5 years

Total Amount AUD$:

$2809149.60

 

3. Title:

Cellular and molecular correlates to SARS CoV2 immunity in convalescent patients: MRF2005760

Chief investigators:

S Turville, G Matthews, M davenport, J Zaunders, T Phan, F Luciani, W Rawlinson, I Gosbell

Role in Project:

CIA

Source and Scheme:

MRFF:

Commencement date:

January 2021

Duration:

2 years

Total Amount AUD$:

$994584

 

  1. Title:

Hyperimmune globulin: a rapid pathway to treatment of COVID-19: MRF2001684

Chief investigators:

A Kelleher, G Symonds, M Polizzotto, M Law, L Evans, S Turville,  M O’Sullivan

Role in Project:

CIF

Source and Scheme:

MRFF:

Commencement date:

June 2020

Duration:

2 years

Total Amount AUD$:

$2065257.15

 

  1. Title:

Gene Therapy for a HIV Cure 2019/GNT1183065

Chief investigators:

S Turville, J Hoxie, G Symonds

Role in Project:

CIA

Source and Scheme:

NHMRC Ideas Grant

Commencement date:

January 2019

Duration:

4 years

Total Amount AUD$:

$841489.60

 

ILP, Honours, masters, PhD

HIV basic biology and pathogenesis. HIV transmission. Viral based gene Gene Therapies